Placental biogenic amine transporters: Cloning and expression

Molecular Brain Research

Volumn 45, Issue 1, 1997, Pages 163-168

  Padbury, James F ^a   Tseng, Yi Tang ^a   McGonnigal, Bethany ^a   Penado, Kendall ^b   Stephan, Megan ^b   Rudnick, Gary ^b  

^a BROWN UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biogenic amine; Catecholamine (CA); Dopamine transporter (DAT); Norepinephrine transporter (NET); Serotonin transporter (SERT)

Indexed keywords

CATECHOLAMINE; COCAINE; NEUROTRANSMITTER; NORADRENALIN TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; MOLECULAR CLONING; NONHUMAN; PLACENTA; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; SHEEP;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BRAIN; CARRIER PROTEINS; CELL MEMBRANE; CLONING, MOLECULAR; FEMALE; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEURONS; PLACENTA; PREGNANCY; PROTEIN BIOSYNTHESIS; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SHEEP;

EID: 0031127034     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(96)00309-9     Document Type: Article

References (30)

1. [1] Esler, M., Jackman, G., Bobik, A., Leonard, P., Kelleher, D., Skews, H., Jennings, G. and Korner, P., Norepinephrine kinetics in essential hypertension. Detective neuronal uptake of norepinephrine in some patients, Hypertension, 3 (1981) 149-156.
2. [2] Esler, M., Jennings, G., Lambert, G., Meredith, I., Horne, M. and Eisenhofer, G., Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions, Pharmacol, Rev., 70 (1990) 963-985.
3. [3] Brush, Jr., J.E., Eisenhofer, G., Garty, M., Stull, R., Maron, B.J., Cannon, III, R.O., Panza, J.A., Epstein, S.E. and Goldstein, D.S., Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy, Circulation, 79 (1989) 836-844.
4. [4] Case, W.A., Gerhardt, G.A., Mayfield, R.D., Curella, P. and Zahniser, N.R., Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration, J. Neurochem., 59 (1992) 259-266.
5. [5] Padbury, J.F., Ludlow, J.K., Humme, J.A. and Agata, Y., Metabolic clearance and plasma appearance rates of catecholamines in preterm and term fetal sheep, Pediatr. Res., 20 (1986) 992-995.
6. [6] Stein, H., Oyama, K., Martinez, A., Chappel, B. and Padbury, J.F., Plasma epinephrine appearance and clearance rates in fetal and newborn sheep, Am. J. Physiol. (Regul. Integr. Comp. Physiol., 34) (1993) R756-R760.
7. [7] Bzoskie, L., Blount, L., Kashiwai, K., Tseng, Y.-T., Hay, Jr., W.W. and Padbury, J.F., Placental norepinephrine clearance: in vivo measurement and physiological role, Am. J. Physiol., 269 (Endocrinol. Metab., 32) (1995) E145-E149.
8. [8] Bzoskie, L., Blount, L., Kashiwai, K., Humme, J. and Padbury, J.F., Placental norepinephrine transporter development in the ovine fetus, Placenta (in press).
9. [9] Pacholczyk, T., Blakely, R.D. and Amara, S.G., Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter, Nature, 350 (1991) 350-354.
10. [10] Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162 (1987) 156-159.
11. [11] Blakely, R.D., Moore, K.R. and Qian, Y., Tails of serotonin and norepinephrine transporters: deletions and chimeras retain function, Soc. Gen. Physiol. Serv., 48 (1993) 283-300.
12. [12] Moore, R.D. and Blakely, R.D., Restriction site-independent formation of chimeras from homologous neurotransmitter-transporter cDNAs, Biotechniques, 17 (1994) 130-135.
13. [13] Ramamoorthy, S., Bauman, A.I.L., Moore, K.R., Han, H., Yang-Feng, T., Chang, A.S., Ganapathy, V. and Blakely, R.D., Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization, Proc. Natl. Acad. Sci. USA, 90 (1993) 2542-2556.
14. [14] Blakely, R.D., Clark, J.A., Rudnick, G. and Amara, S.G., Vaccinia-T7 RNA polymerase expression system: evaluation for the expression cloning of membrane transporters, Anal. Biochem., 194 (1991) 302-308.
15. [15] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J., Protein measurement with Folin phenol reagent, J. Biol. Chem., 193 (1951) 265-275.
16. [16] Zea-Ponce, Y., Baldwin, R.M., Laurelle, M., Wang, S., Neumeyer, J.L. and Innis, R.B., Simplified multidose preparation of iodine-123-beta-CIT; a marker for dopamine transporters, J. Nucl. Med., 36 (1995) 525-529.
17. [17] Ganapathy, G., Ramamoorthy, S. and Leibach, F., Transport and metabolism of monoamines in the human placenta, Trophoblast Res., 7 (1993) 35-51.
18. [18] Jayanthi, L.D., Prasad, P.D., Ramamoorthy, S., Mahesh, V.B., Leibach, F.H. and Ganapathy, V., Sodium- and chloride-dependent, cocaine-sensitive, high-affinity binding of nisoxetine to the human placental norepinephrine transporter, Biochemistry, 32 (1993) 12178-12185.
19. [19] Ramamoorthy, S., Prasad, P.D., Kulanthivel, P., Leibach, F.H., Blakely, R.D. and Ganapathy, V., Expression of a cocaine-sensitive norepinephrine transporter in the human placental syncytiotrophoblast, Biochemistry, 32 (1993) 1346-1353.
20. [20] Ramamoorthy, S., Leibach, F.H., Mahesh, V.B. and Ganapathy, V., Active transport of dopamine in human placental brush-border membrane vesicles, Am. J. Physiol., 262 (Cell Physiol., 31) (1992) C1189-C1196.
21. [21] Moe, A.J., Placental amino acid transport, Am. J. Physiol., 268 (Cell Physiol., 37) (1995) C1321-C1331.
22. [22] Barros, L.F., Yudilevich, D.L., Jarvis, S.M., Beaumont, N. and Baldwin, S.A., Quantitation and immunolocalization of glucose transporters in the human placenta, Placenta, 16 (1995) 623-633.
23. [23] Prasad, P.D., Ramamoorthy, S., Leibach, F.H. and Ganapathy, V., Molecular cloning of the human placental folate transporter, Biochem. Biophys. Res. Commun., 206 (1995) 681-687.
24. [24] Amara, S. and Kuhar, M., Neurotransmitter transporters: recent progress, Annu. Rev. Neurosci., 16 (1993) 73-93.
25. [25] Blakely, R.D., De Felice, L.J. and Hartzell, H.C., Molecular physiology of norepinephrine and serotonin transporters, J. Exp. Biol., 196 (1994) 263-281.
26. [26] Bzoskie, L., Blount, L., Kashiwai, K., Humme, J. and Padbury, J.F., The contribution of transporter-dependent uptake to fetal catecholamine clearance, Biol. Neonate (in press).
27. [27] Bzoskie, L., Yen, J., Tseng, Y.T., Blount, L., Kashiwai, K. and Padbury, J.F., Human placental norepinephrine transporter mRNA: expression and correlation with fetal condition at birth, Placenta (in press).
28. [28] Naeye, R.L., In Disorders of the Placenta, Fetus and Neonate: Diagnosis and Clinical Significance, Mosby Year Book, 1992, Mosby, St. Louis. MO, USA.
29. [29] Jansson, T., Responsiveness to norepinephrine of the vessels supplying the placenta of growth-retarded fetuses, Am. J. Obstet. Gynecol., 158 (1988) 1233-1237.
30. [30] Jones, C.T. and Robinson, J.S., Studies on experimental growth retardation in sheep. Plasma catecholamines in fetuses with small placentas, J. Dev. Physiol., 5 (1983) 77-87.